ArticleDrug target insights

Ravulizumab in treatment-naïve patients with atypical hemolytic uremic syndrome: a real-world case series.

Sorrentino Livia Maria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.